Bioactivity assay development consultant support services
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00683
- Awardee
-
In Vitro Strategies LIMITED Liability Company UEI NFQKQ992KJD4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $150,000
Award facts
- Opportunity
-
- Bioactivity Assay Development Consultant Support Services Solicitation · NIHNINDSCSS21000198 · Posted Aug 10, 2021
- Contract value 34% obligated
-
- $150,000.00 Current, with exercised options
- $444,500.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Flemington, NJ 08822, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $9,250 | |
| Exercise an Option | $72,150 | |
| Exercise an Option | $10,800 | |
| Exercise an Option | $18,500 | |
| Exercise an Option | $27,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $12,300 |
About this award
This is a $444,500.00 labor-hour federal contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to In Vitro Strategies Limited Liability Company, a woman-owned small business. The contract is for the provision of senior-level consultant support services for bioactivity assay development to support the NINDS Blueprint Neurotherapeutics Program and other NIH neuroscience-focused drug development initiatives. The contract has a one-year base period with two one-year option periods. This is a total small business set-aside contract.
Quick answers
Who was awarded contract 75N95021P00683?
75N95021P00683 was awarded to In Vitro Strategies LIMITED Liability Company by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2021.
How much is contract 75N95021P00683 worth?
The government has obligated $150,000 on 75N95021P00683. Its potential value, with all options, is $444,500.
Which agency awarded contract 75N95021P00683?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00683, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95021P00683 competed?
The extent of competition for 75N95021P00683 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award